IGAC
NASDAQ · N/A
Invest Green Acquisitio-Cl A
$10.01
+0.01 (+0.10%)
IGAC News30 articles
Stealth Bomber Fires Anti-Ship Missile in Pacific Test; Investor Focus on Lockheed, Northrop
The B-2 Spirit bomber fired a Lockheed Martin AGM-158C LRASM in a Pacific sinking drill, the first public integration of the stealth bomber with the missile. The Navy seeks $531.4 million for 120 LRASMs in FY2026.
Intel's Foundry Ambitions Face Investor Scrutiny Amid Sector Rebound
Intel shares gained 0.51% premarket Monday but trailed the broader chip sector rebound, as investor attention turns to the company's foundry roadmap and 14A process timeline.
South Korea's $518B Chip Plan Fails to Impress Investors
South Korea's revised 800 trillion won ($518.3B) chip plan, down 60% from earlier estimates, sent Samsung down 4.86% and SK Hynix down 1.68% as investors focused on capex load.
Trump-Linked Investors Scrutinized as Skyline Secures $1.6B U.S. Interest for Kazakhstan Tungsten Mine
Skyline (NASDAQ:KAZR) lands $1.6B in nonbinding U.S. agency interest for its $1.1B Kazakhstan tungsten project, with political ties to Trump and Lutnick families under scrutiny.
Crypto Sell-Off Deepens as AI Stocks Lure Investors; Gold Miner i-80 Reports Progress
Cryptocurrencies dropped nearly 9% as AI stocks gained favor. i-80 Gold released drill results, NSE plans a major IPO, Vizsla Silver advances its mine strategy, and US-Iran tensions keep oil steady.
Volkswagen Eyes Up to 100,000 Job Cuts and €23 Billion Investment Reduction
Volkswagen (VOW3) reportedly plans up to 100,000 job cuts, four German plant closures, and a €23 billion investment reduction, reflecting severe margin pressures.
Polymarket Hack Exposes Frontend Risks Amid ICE's $2B Investment Plan
Polymarket will fully refund users after a third-party vendor hack drained nearly $3 million from fewer than 15 accounts, shifting security focus from smart contracts to frontend vulnerabilities as ICE plans a $2 billion investment.
Pfizer's 7% Yield Draws Income Investors Amid Mixed Drug News
Pfizer's yield surpasses 7% as shares decline, FDA clears Ibrance for expanded use, but a lung cancer drug fails late-stage trial, highlighting income appeal versus uneven growth.
Microsoft's $386.6B AI Bet Tests Investor Patience
Microsoft shares have dropped 24% year-to-date, weighed down by massive AI infrastructure spending and regulatory risks, despite strong cloud sales growth.
Strategy Inc Shares Tumble as Bitcoin Buying Strategy Faces Investor Backlash
Strategy Inc shares plunged 5.2% to $98.45 after selling $335.5 million in stock to buy 520 bitcoin, raising concerns as dollar reserves dropped 38% and dividend coverage shrank.
Foreign Investors Retreat $8.6 Billion from Korean and Taiwanese Markets
Foreign investors withdrew $8.6 billion from South Korean and Taiwanese equities, even as the KOSPI rebounded 3.3%. Samsung Electronics jumped 9.84% on a reported $58.6 billion buyback plan, but analysts flag risks from retail trading and concentrated chip stock exposure.
Broadcom Drops 3% as AI Chip Spending Concerns Weigh on Investors
Broadcom shares dropped 2.8% on Tuesday, as investor concerns about AI funding among its top cloud customers offset strong revenue growth and a bullish AI chip outlook.
Micron's Strategic Investment Boosts Anthropic Ahead of IPO, Financial Transparency Key
Micron Technology secures a strategic investment and supply deal with Anthropic ahead of its IPO, as the AI firm faces pressure to disclose key financial metrics like gross margin.
Meta Invests $900M in CRED, Names Kunal Shah as WhatsApp Head
Meta is investing $900 million in Indian fintech CRED and appointing its founder Kunal Shah as WhatsApp's new global head, signaling a major push into payments and AI-driven commerce.
Fiserv Insiders Invest $1.72M Amid CEO Shakeup, Stock Lags
Six Fiserv insiders purchased 34,781 shares worth $1.72 million following CEO Mike Lyons' sudden departure, but FISV closed at $47.86, below their average cost.
SoFi Gains 8% in Short Week as Investors Eye Growth and Credit Risks
SoFi shares surged 8% in a shortened trading week, buoyed by strong Q1 results and investor confidence, though unchanged 2026 guidance and credit risks remain in focus.
Pfizer Shares Slip as CFO Departure Rattles Investors; 2026 Outlook Intact
Pfizer shares fell 2.7% to $25.21 after CFO Dave Denton said he will leave in August, reigniting investor concerns over succession and obesity-drug competition.
Cathie Wood's ARK Invests $52M in Snowflake, Betting on AI Cloud Growth
ARK Investment Management bought $52 million in Snowflake shares following a 33% surge driven by raised guidance and a $6 billion AWS deal, signaling a bet on AI software revenue.
MELI Edges Higher as Investors Eye Growth Spending Amid Ownership Shift
MercadoLibre shares rose 2.9% last week, but remain down 18.82% YTD. An internal estate-planning trust transfer left ownership unchanged, while investors weigh heavy growth spending in Brazil and Mexico.
U.S. Mint's America 250 Silver Eagle Sales Resume; Collectors Warned on Investment Potential
The U.S. Mint will resume sales of its 250th-anniversary Proof American Silver Eagle on June 24 after the first batch sold out in 17 minutes. Dealers warn collectors not to expect investment gains.
Plug Power Gains 7.55% as Investors Eye Key Asset Sale Deadline
Plug Power shares jumped 7.55% to $2.85 on Thursday, capping a holiday-shortened week. Investors await the June 30 deadline for a $132.5 million asset sale crucial to the company's liquidity.
SpaceX ETF Frenzy Sparks Concerns Over Retail Investor Risk
SpaceX's first week as a public company saw over $10 billion in leveraged ETF trading and record ARK Innovation flows, raising concerns about retail investor risk amid high volatility.
UiPath Shares Dip as AI Automation Product Launch Fails to Impress Investors
UiPath shares closed at $10.27, down nearly 3% for the week, as the market remains skeptical about the company's new AI product launch and looks for stronger growth signals.
Snap Shares Dip as $2,195 Specs Launch Fails to Impress Investors
Snap shares dropped 1.69% to $4.66, marking a third straight loss, as investors reacted skeptically to the $2,195 Specs AR glasses launch and CEO Evan Spiegel's long-term profit focus.
Bezos Reportedly Called Washington Post 'Worst Investment' to Trump
A forthcoming book alleges Jeff Bezos told Donald Trump in December 2024 that buying The Washington Post was his worst investment, amid major layoffs and business struggles.
Accenture Stock Dips on Weak Outlook Despite $4.18B Cybersecurity Investment
Accenture slashed its full-year revenue growth forecast and issued weak Q4 guidance, sending shares lower premarket despite a $4.18 billion cybersecurity acquisition announcement.
Keel Infrastructure's AI Data Center Push and Auditor Change Draw Investor Scrutiny
Keel Infrastructure traded at $6.2037 in premarket as investors weighed its $458M convertible debt raise, auditor change, and U.S. domicile shift. Revenue fell 23% and adjusted EBITDA turned negative in Q1.
Snap Stock Plunges 8% on $2,195 AR Spectacles Launch, Investor Skepticism
Snap shares tumbled 8.1% after launching $2,195 Specs AR glasses, as investors question the device's ability to revive growth without draining cash.
Snap Shares Plunge After $2,195 AR Glasses Launch Sparks Investor Skepticism
Snap shares tumbled 9.63% to $5.16 after launching $2,195 Specs AR glasses, as investors question demand and profitability amid activist pressure.
SRx Health Solutions Surges as Crypto Pivot Fuels Investor Interest
SRx Health Solutions shares surged 21% to $0.19 on heavy volume as investors tracked its pivot to EMJ Crypto Technologies and digital-asset treasury management, but the $55 million all-stock deal faces closing conditions and dilution risk.